Top 10 Companies in the Madecassoside Powder Market (2026): Market Leaders Driving Global Therapeutic Innovation

The Madecassoside Powder market was valued at USD 64 million in 2023 and is projected to reach USD 97.9 million by 2030, at a CAGR of 6.3% during the forecast period. The influence of COVID‑19 and the Russia‑Ukraine War were considered while estimating market sizes.

Madecassoside Powder Market – View in Detailed Research Report

Market Insight

The global Madecassoside Powder market is expanding as pharmaceutical and cosmetic manufacturers seek natural anti‑inflammatory and skin‑repair agents. With a modest base of USD 64 million in 2023, the industry is poised to grow to USD 97.9 million by 2030, reflecting a steady 6.3% annual increase. The forecast period of 2025‑2034 highlights a trajectory where demand is driven by evolving therapeutic indications, heightened consumer preference for botanical ingredients, and supportive regulatory frameworks.

Product Definition

Madecassoside is a triterpenoid extracted from Centella asiatica, known for its antioxidant, anti‑inflammatory, and wound‑healing properties. In powder form, it is used as an active ingredient in topical formulations, oral supplements, and as a research reagent. Its high purity grades (0.8, 0.9, 0.95) cater to both pharmaceutical and cosmetic segments, while “others” capture lower‑grade bulk material used in large‑scale manufacturing.

Top 10 Companies in the Madecassoside Powder Market (2026)

🔟 1. Luck Herb Biotechnology Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity Madecassoside Powder (0.95%) for pharmaceutical and cosmetic use

Luck Herb Biotechnology has positioned itself as a leading supplier of botanical raw materials. The company’s vertical integration—from cultivation to extraction—ensures consistent quality and cost control. Recent investments in a GMP‑certified extraction plant have expanded capacity by 30% and lowered production costs by 12%.

Sustainability Initiatives:

• Adoption of renewable energy for extraction processes
• Closed‑loop water recycling reducing consumption by 25%
• Certification of sustainable sourcing for Centella asiatica

🕘 2. Xi’an Gaoyuan Bio‑Chem Co., Ltd.

Headquarters: Xi’an, China
Key Offering: Bulk Madecassoside Powder (0.8%) for research and industrial use

Xi’an Gaoyuan’s focus on cost‑effective bulk production has made it a preferred partner for emerging markets. The company’s recent partnership with a leading cosmetic brand in Southeast Asia has secured a multi‑year supply agreement, reinforcing its regional footprint.

Growth Initiatives:

• Expansion of extraction capacity by 20% in 2026
• Development of a new high‑purity line (0.99%) for pharma applications
• Strategic alliance with a Chinese university for R&D in anti‑aging therapeutics

🕗 3. Kono Chem Co., Ltd.

Headquarters: Osaka, Japan
Key Offering: Specialty Madecassoside Powder for dermatological products

Kono Chem leverages its expertise in natural product chemistry to deliver highly refined powders. The company’s recent launch of a 0.95% purity line has attracted attention from premium skincare brands seeking proven efficacy.

Key Initiatives:

• Investment in advanced chromatography techniques to reduce impurities
• Collaboration with a global pharma firm to explore oral delivery systems
• Commitment to ISO 9001 and ISO 14001 certifications

🕘 4. Xi’an Chen Lang Biological Technology Co., Ltd.

Headquarters: Xi’an, China
Key Offering: Bulk and high‑purity Madecassoside Powder for nutraceuticals and cosmetics

The company’s dual‑facility model—combining cultivation and extraction—allows rapid scaling. In 2026, it plans to launch a new 0.9% purity line to meet the growing demand from the Asian nutraceutical market.

Strategic Moves:

• Acquisition of a small biotech focused on anti‑oxidant extraction
• Implementation of AI‑driven process monitoring to improve yield
• Expansion of export agreements to the Middle East

🕙 5. Shanghai CRM New Material Technology Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Advanced Madecassoside Powder for pharmaceutical APIs

Shanghai CRM’s reputation for precision extraction positions it as a preferred supplier for high‑regulatory markets. The company’s recent partnership with a European pharmaceutical group underscores its credibility.

Innovation Highlights:

• Development of a green extraction solvent reducing VOC emissions
• Launch of a 0.95% purity line in 2026
• Strategic collaboration with a global clinical research organization

🕚 6. Wuhan Senwayer Century Chemical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: Bulk Madecassoside Powder for industrial applications

Wuhan Senwayer’s focus on cost efficiency has driven it to become a leading bulk supplier. The company’s recent investment in a new extraction plant has increased output by 18% and positioned it to capture emerging demand in the cosmetics sector.

Growth Drivers:

• Expansion of export market to Southeast Asia
• Development of a low‑cost 0.8% purity line for large‑scale production
• Strategic partnership with a Chinese university for process optimization

🕛 7. Shenzhen Feiming Science and Technology Co., Ltd.

Headquarters: Shenzhen, China
Key Offering: High‑purity Madecassoside Powder for topical formulations

Feiming’s strong R&D capabilities enable it to produce highly refined powders. The company’s 2026 roadmap includes a 0.99% purity line aimed at premium skincare brands.

Key Initiatives:

• Investment in high‑pressure liquid chromatography to reduce impurities
• Collaboration with a global cosmetics firm for product development
• Commitment to eco‑friendly packaging solutions

1️⃣ 8. Xi’an Huilin Bio‑tech Co., Ltd.

Headquarters: Xi’an, China
Key Offering: Bulk Madecassoside Powder for nutraceuticals

Huilin’s focus on scalability has led to a 25% increase in production capacity in 2025. The company is exploring new extraction techniques to further reduce production costs.

Strategic Moves:

• Partnership with a leading nutraceutical distributor in India
• Implementation of a lean manufacturing framework
• Expansion of product portfolio to include complementary botanical extracts

2️⃣ 9. Shenyang Phytocare Ingredients Co., Ltd.

Headquarters: Shenyang, China
Key Offering: Bulk and high‑purity Madecassoside Powder for pharmaceutical use

Phytocare’s integrated supply chain allows rapid response to market demand. The company’s recent acquisition of a small extraction facility has increased its output by 15%.

Growth Initiatives:

• Expansion of export agreements to the Middle East
• Development of a 0.95% purity line for advanced therapeutics
• Implementation of a digital traceability system for raw materials

3️⃣ 10. Plamed Green Science Group

Headquarters: Beijing, China
Key Offering: Specialty Madecassoside Powder for cosmetic and pharmaceutical markets

Plamed’s emphasis on sustainability and quality has earned it a reputation among premium brands. The company’s 2026 plan includes a new green extraction line and a partnership with a European skincare manufacturer.

Key Initiatives:

• Launch of a 0.99% purity line using renewable solvents
• Strategic alliance with a global cosmetics brand for joint product development
• Implementation of a blockchain system for supply‑chain transparency

Download FREE Sample Report: Madecassoside Powder Market – View in Detailed Research Report

Get Full Report: Madecassoside Powder Market – View in Detailed Research Report

Outlook

The Madecassoside Powder market is shifting toward higher‑purity grades as pharmaceutical and cosmetic manufacturers demand greater efficacy and regulatory compliance. Geographic expansion into Southeast Asia and the Middle East is expected to drive volume growth, while ongoing R&D into novel delivery systems—such as nano‑encapsulation—will open new therapeutic avenues.

Future Trends

• Digitalization of extraction and quality control processes to enhance traceability and reduce batch variability
• Adoption of green chemistry principles, including renewable solvents and energy‑efficient extraction methods
• Integration of artificial intelligence for predictive process optimization and yield improvement
• Expansion of partnerships between raw‑material suppliers and formulation companies to accelerate product development cycles
• Growing regulatory focus on botanical ingredient safety, encouraging higher purity standards and rigorous testing